Exercise or conversion by Dake Benjamin T of 8700 shares of Aerovate Therapeutics subject to Rule 16b-3

AVTE
 Stock
  

USD 16.58  0.86  5.47%   

Aerovate investor sentiment overview provides quick insight into current market opportunities from investing in Aerovate Therapeutics. The current market sentiment together Aerovate Therapeutics' historical and current headlines can help investors to time the market. Many technical investors use Aerovate Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to Aerovate Therapeutics Hype Analysis, Aerovate Therapeutics Correlation and Aerovate Therapeutics Performance.
  
Aerovate Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aerovate daily returns and investor perception about the current pice of Aerovate Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Filed transaction by Aerovate Therapeutics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Aerovate insider trading alert for exercise of stock option (right to buy) by Dake Benjamin T, Officer Title: President Chief Operating Officer and Secretary, on 10th of August 2022. This event was filed by Aerovate Therapeutics Inc with SEC on 2022-08-10. Statement of changes in beneficial ownership - SEC Form 4

Aerovate Therapeutics Investor Sentiment by Other News Outlets

Aerovate Therapeutics Fundamental Analysis

We analyze Aerovate Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aerovate Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aerovate Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Aerovate Therapeutics is currently under evaluation in short ratio category among related companies. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Aerovate Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aerovate Therapeutics stock to make a market-neutral strategy. Peer analysis of Aerovate Therapeutics could also be used in its relative valuation, which is a method of valuing Aerovate Therapeutics by comparing valuation metrics with similar companies.
Please continue to Aerovate Therapeutics Hype Analysis, Aerovate Therapeutics Correlation and Aerovate Therapeutics Performance. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for analysis

When running Aerovate Therapeutics price analysis, check to measure Aerovate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aerovate Therapeutics is operating at the current time. Most of Aerovate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aerovate Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aerovate Therapeutics' price. Additionally, you may evaluate how the addition of Aerovate Therapeutics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Aerovate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aerovate Therapeutics. If investors know Aerovate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aerovate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aerovate Therapeutics is measured differently than its book value, which is the value of Aerovate that is recorded on the company's balance sheet. Investors also form their own opinion of Aerovate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aerovate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aerovate Therapeutics' market value can be influenced by many factors that don't directly affect Aerovate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aerovate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Aerovate Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aerovate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.